Dermata Therapeutics, Inc. Warrant
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch DRMAW and buy or sell other stocks, ETFs, and their options commission-free!About DRMAW
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410.
CEOGerry Proehl, MBA
CEOGerry Proehl, MBA
Employees—
Employees—
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2014
Founded2014
Employees—
Employees—
DRMAW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume7.64K
Average volume7.64K
High today$0.019
High today$0.019
Low today$0.019
Low today$0.019
Open price$0.019
Open price$0.019
Volume6.33K
Volume6.33K
52 Week high$0.044
52 Week high$0.044
52 Week low$0.0081
52 Week low$0.0081
Stock Snapshot
Dermata Therapeutics, Inc. Warrant(DRMAW) stock is priced at $0.02.
On 2025-12-12, Dermata Therapeutics, Inc. Warrant(DRMAW) stock traded between a low of $0.02 and a high of $0.02. Shares are currently priced at $0.02, which is 0.0% above the low and 0.0% below the high.
The Dermata Therapeutics, Inc. Warrant(DRMAW)'s current trading volume is 6.33K, compared to an average daily volume of 7.64K.
In the last year, Dermata Therapeutics, Inc. Warrant(DRMAW) shares hit a 52-week high of $0.04 and a 52-week low of $0.01.
In the last year, Dermata Therapeutics, Inc. Warrant(DRMAW) shares hit a 52-week high of $0.04 and a 52-week low of $0.01.